JP2023501745A5 - - Google Patents
Info
- Publication number
- JP2023501745A5 JP2023501745A5 JP2022528582A JP2022528582A JP2023501745A5 JP 2023501745 A5 JP2023501745 A5 JP 2023501745A5 JP 2022528582 A JP2022528582 A JP 2022528582A JP 2022528582 A JP2022528582 A JP 2022528582A JP 2023501745 A5 JP2023501745 A5 JP 2023501745A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- pharmaceutical composition
- hypercholesterolemia
- binding fragment
- ldl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025133754A JP2025172265A (ja) | 2019-11-18 | 2025-08-08 | 抗ｐｃｓｋ９抗体及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911132974.4 | 2019-11-18 | ||
| CN201911132974 | 2019-11-18 | ||
| CN201911133187.1 | 2019-11-18 | ||
| CN201911133187 | 2019-11-18 | ||
| PCT/CN2020/129763 WO2021098720A1 (zh) | 2019-11-18 | 2020-11-18 | 抗pcsk9抗体及其应用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025133754A Division JP2025172265A (ja) | 2019-11-18 | 2025-08-08 | 抗ｐｃｓｋ９抗体及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023501745A JP2023501745A (ja) | 2023-01-18 |
| JP2023501745A5 true JP2023501745A5 (cg-RX-API-DMAC10.html) | 2023-11-21 |
Family
ID=75853278
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022528582A Pending JP2023501745A (ja) | 2019-11-18 | 2020-11-18 | 抗ｐｃｓｋ９抗体及びその使用 |
| JP2025133754A Pending JP2025172265A (ja) | 2019-11-18 | 2025-08-08 | 抗ｐｃｓｋ９抗体及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025133754A Pending JP2025172265A (ja) | 2019-11-18 | 2025-08-08 | 抗ｐｃｓｋ９抗体及びその使用 |
Country Status (12)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4548931A1 (en) * | 2022-06-30 | 2025-05-07 | AD Pharmaceuticals Co., Ltd. | Anti-pcsk9 antibody preparation and use thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20080381B1 (ar) * | 2007-08-23 | 2023-03-28 | Amgen Inc | بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9) |
| CN102232088A (zh) * | 2007-10-26 | 2011-11-02 | 先灵公司 | 用于治疗脂类和胆固醇疾病的抗pcsk9及方法 |
| US20130064834A1 (en) * | 2008-12-15 | 2013-03-14 | Regeneron Pharmaceuticals, Inc. | Methods for treating hypercholesterolemia using antibodies to pcsk9 |
| JOP20200043A1 (ar) * | 2011-05-10 | 2017-06-16 | Amgen Inc | طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول |
| EA039663B1 (ru) * | 2012-05-03 | 2022-02-24 | Амген Инк. | Применение антитела против pcsk9 для снижения сывороточного холестерина лпнп и лечения связанных с холестерином расстройств |
| US9255154B2 (en) * | 2012-05-08 | 2016-02-09 | Alderbio Holdings, Llc | Anti-PCSK9 antibodies and use thereof |
| TWI682780B (zh) * | 2013-05-30 | 2020-01-21 | 美商再生元醫藥公司 | 醫藥組成物用於製造治療與ｐｃｓｋ９功能獲得性突變有關之體染色體顯性高膽固醇血症的藥物之用途 |
| MX373298B (es) * | 2013-10-11 | 2020-05-20 | Sanofi Biotechnology | Uso de un inhibidor de pcsk9 para tratar la hiperlipidemia. |
| CN114558129A (zh) * | 2014-03-17 | 2022-05-31 | 赛诺菲生物技术公司 | 用于降低心血管风险的方法 |
| KR20230074283A (ko) * | 2014-07-16 | 2023-05-26 | 사노피 바이오테크놀로지 | 이형접합성 가족성 고콜레스테롤혈증(heFH) 환자의 치료방법 |
| AU2015289617B2 (en) * | 2014-07-16 | 2021-04-15 | Regeneron Pharmaceuticals, Inc. | Methods for treating high cardiovascular risk patients with hypercholesterolemia |
| CN105461809B (zh) * | 2015-02-11 | 2018-10-12 | 康融东方（广东）医药有限公司 | Pcsk9抗体、其药物组合物及其用途 |
| EA201890519A1 (ru) * | 2015-08-18 | 2018-07-31 | Ридженерон Фармасьютикалз, Инк. | Ингибирующие антитела против pcsk9 для лечения пациентов с гиперлипидемией, подвергающихся аферезу липопротеинов |
| CN108239150A (zh) * | 2016-12-24 | 2018-07-03 | 信达生物制药(苏州)有限公司 | 抗pcsk9抗体及其用途 |
-
2020
- 2020-11-18 JP JP2022528582A patent/JP2023501745A/ja active Pending
- 2020-11-18 IL IL292973A patent/IL292973B2/en unknown
- 2020-11-18 EP EP20888942.8A patent/EP4063396A4/en active Pending
- 2020-11-18 IL IL323016A patent/IL323016A/en unknown
- 2020-11-18 CN CN202011297250.8A patent/CN112812188A/zh active Pending
- 2020-11-18 WO PCT/CN2020/129763 patent/WO2021098720A1/zh not_active Ceased
- 2020-11-18 BR BR112022009587A patent/BR112022009587A2/pt unknown
- 2020-11-18 KR KR1020227020280A patent/KR20220107210A/ko active Pending
- 2020-11-18 MX MX2022005959A patent/MX2022005959A/es unknown
- 2020-11-18 PH PH1/2022/551172A patent/PH12022551172A1/en unknown
- 2020-11-18 CA CA3160071A patent/CA3160071A1/en active Pending
- 2020-11-18 US US17/776,295 patent/US20230312750A1/en not_active Abandoned
- 2020-11-18 AU AU2020388182A patent/AU2020388182A1/en active Pending
-
2025
- 2025-08-08 JP JP2025133754A patent/JP2025172265A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250332254A1 (en) | Methods for treating patients with familial hypercholesterolemia | |
| TWI705826B (zh) | 特異性結合pcsk9之單株抗體用於治療或預防膽固醇相關疾病之用途 | |
| JP2019514907A5 (cg-RX-API-DMAC10.html) | ||
| US20240197870A1 (en) | Methods for treating patients with refractory hypercholesterolemia | |
| JP2025172265A (ja) | 抗ｐｃｓｋ９抗体及びその使用 | |
| JP2023506732A (ja) | ホモ接合型家族性高コレステロール血症を処置するためのｐｃｓｋ９阻害剤の使用 | |
| WO2021185344A1 (zh) | 一种胆固醇相关疾病的治疗方法 | |
| EA049226B1 (ru) | Анти-pcsk9 антитело и его применение | |
| HK40003056A (en) | Methods for treating patients with familial hypercholesterolemia | |
| HK40003056B (en) | Methods for treating patients with familial hypercholesterolemia | |
| NZ717550B2 (en) | Methods of treating or preventing cholesterol related disorders |